| Title |
Cannabidiol as a Potential Treatment for Anxiety Disorders
|
|---|---|
| Published in |
Neurotherapeutics, October 2015
|
| DOI | 10.1007/s13311-015-0387-1 |
| Pubmed ID | |
| Authors |
Esther M Blessing, Maria M Steenkamp, Jorge Manzanares, Charles R Marmar |
X Demographics
The data shown below were collected from the profiles of 221 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 69 | 31% |
| Canada | 14 | 6% |
| United Kingdom | 10 | 5% |
| Switzerland | 2 | <1% |
| Denmark | 2 | <1% |
| Portugal | 2 | <1% |
| Ireland | 2 | <1% |
| Brazil | 2 | <1% |
| Spain | 1 | <1% |
| Other | 14 | 6% |
| Unknown | 103 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 198 | 90% |
| Practitioners (doctors, other healthcare professionals) | 16 | 7% |
| Scientists | 4 | 2% |
| Science communicators (journalists, bloggers, editors) | 3 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Austria | 1 | <1% |
| Unknown | 1134 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 186 | 16% |
| Student > Master | 136 | 12% |
| Researcher | 126 | 11% |
| Student > Ph. D. Student | 106 | 9% |
| Other | 75 | 7% |
| Other | 159 | 14% |
| Unknown | 349 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 157 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 100 | 9% |
| Neuroscience | 94 | 8% |
| Agricultural and Biological Sciences | 78 | 7% |
| Psychology | 76 | 7% |
| Other | 248 | 22% |
| Unknown | 384 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2234. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#3,864
of 25,888,065 outputs
Outputs from Neurotherapeutics
#1
of 1,320 outputs
Outputs of similar age
#22
of 287,898 outputs
Outputs of similar age from Neurotherapeutics
#1
of 19 outputs
Altmetric has tracked 25,888,065 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,320 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,898 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.